Factors affecting influenza vaccination in adults aged 50-64 years with high-risk chronic diseases in South Korea.

07:00 EST 14th December 2018 | BioPortfolio

Summary of "Factors affecting influenza vaccination in adults aged 50-64 years with high-risk chronic diseases in South Korea."

Influenza is a communicable disease with most of the mortality burden falling on high-risk populations and those with pre-existing comorbidities and chronic diseases. In South Korea, adults aged 50-64 years are recommended for influenza vaccination, but no government financial support is offered to encourage vaccination uptake, which has led to suboptimal vaccination rates and significant public health concerns. The purpose of this study was to identify the factors affecting influenza vaccine uptake in adults aged 50-64 years and to compare high-risk and non-high-risk groups. We conducted randomized telephone questionnaires in South Korea on influenza vaccination-related behavioural factors in adults aged 50-64 years based on their vaccination history during the 2015-2016 flu season. The vaccination rate was 29.9% in non-high-risk adults aged 50-64 years and 41.3% in high-risk adults aged 50-64 years, which is considerably lower than the 81.7% rate in adults aged ≥65 years. Individuals who reported awareness of the potential severity of influenza, the importance and safety of vaccination, and who had experienced influenza after immunization or received a healthcare recommendation reported higher influenza vaccination rates. Therefore, highlighting awareness of influenza disease and vaccination through public campaigns and by information from healthcare professionals could represent opportunities to improve vaccination uptake in this population.


Journal Details

This article was published in the following journal.

Name: Human vaccines & immunotherapeutics
ISSN: 2164-554X


DeepDyve research library

PubMed Articles [24037 Associated PubMed Articles listed on BioPortfolio]

Characteristics associated with influenza vaccination uptake among adults.

Annual influenza vaccination has been recommended for all adults since 2010. This study aimed to identify characteristics associated with influenza vaccination among adults.

Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016.

The effects of repeated influenza vaccination in children are not well understood. In this study, we evaluated previous vaccination effects on antibody response after vaccination with trivalent inacti...

Determinants of non-vaccination against seasonal influenza in Canadian adults: findings from the 2015-2016 Influenza Immunization Coverage Survey.

The study objectives were to (1) identify determinants of non-vaccination against seasonal influenza in Canadian adults and (2) examine self-reported reasons for non-vaccination.

Technical guidelines for seasonal influenza vaccination in China, 2018-2019.

Seasonal influenza vaccination is the most effective way to prevent influenza virus infection and its complications. Currently, China has licensed trivalent (IIV3) and quadrivalent inactivated influen...

Knowledge about influenza and adherence to the recommendations for influenza vaccination of pregnant women after an educational intervention in Greece.

Pregnant women and young infants are at increased risk for influenza-associated severe disease, complications and hospitalizations. In Greece influenza vaccination during pregnancy remains extremely l...

Clinical Trials [10228 Associated Clinical Trials listed on BioPortfolio]

Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years

Evaluate the immune response and reactogenicity of H5N1 vaccination in subjects aged 6 months to 17 years compared to seasonal flu vaccination

Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years

The purpose of this Phase 3, observer-blind, placebo-controlled, multi-center study is to characterize the immunogenicity & safety of the investigation vaccination regimen of GSK 1557484A ...

Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above

Evaluate the immune response and reactogenicity of H5N1 vaccination in adults aged 18 years and above (as part of a tetravalent vaccine)

Immune Responses in Health Care Personnel

This is an investigator-initiated 10 year long open cohort observational study, aiming to increase the understanding of the humoral and cellular immunological mechanisms of vaccination aga...

Study of Immune Responses to Influenza Vaccination

Better understanding of the immune responses to influenza vaccination is needed in order to understand situations of poor vaccine response. Adults will receive influenza vaccination and th...

Medical and Biotech [MESH] Definitions

Nutritional physiology of adults aged 65 years of age and older.

A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.

A person 80 years of age and older.

Group activities directed against VACCINATION.

Rate of VACCINATION as defined by GEOGRAPHY and or DEMOGRAPHY.

Quick Search


DeepDyve research library

Relevant Topics

Influenza or 'flu' is a respiratory illness associated with infection by influenza virus. Symptoms frequently include headache, fever, cough, sore throat, aching muscles and joints. There is a wide spectrum of severity of illness ranging from min...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Swine Flu - H1N1 influenza - H7N9
Swine flu is the common name given to a relatively new strain of influenza (flu) that caused a flu pandemic in 2009-2010. It is also referred to as H1N1 influenza (because it is the H1N1 strain of virus). The H1N1 flu virus will be one of the main vi...

Searches Linking to this Article